An evidence-based medicine model for rare and often neglected neoplastic conditions

Charles G. Fisher, Tony Goldschlager, Stefano Boriani, Peter P aul Varga, Laurence D. Rhines, Michael G. Fehlings, Alessandro Luzzati, Mark B. Dekutoski, Jeremy J. Reynolds, Dean Chou, Sigurd H. Berven, Richard P. Williams, Nasir A. Quraishi, Chetan Bettegowda, Ziya L. Gokaslan

Research output: Contribution to journalArticle

Abstract

OBJECT: The National Institutes of Health recommends strategies to obtain evidence for the treatment of rare conditions such as primary tumors of the spine (PTSs). These tumors have a low incidence and are pathologically heterogeneous, and treatment approaches are diverse. Appropriate evidence-based care is imperative. Failure to follow validated oncological principles may lead to unnecessary mortality and profound morbidity. This paper outlines a scientific model that provides significant evidence guiding the treatment of PTSs.

METHODS: A four-stage approach was used: 1) planning: data from large-volume centers were reviewed to provide insight; 2) recruitment: centers were enrolled and provided the necessary infrastructure; 3) retrospective stage: existing medical records were reviewed and completed with survival data; and 4) prospective stage: prospective data collection has been implemented. The AOSpine Knowledge Forum Tumor designed six modules: demographic, clinical, diagnostic, therapeutic, local recurrence, survival, and perioperative morbidity data fields and provided funding.

RESULTS: It took 18 months to implement Stages 1-3, while Stage 4 is ongoing. A total of 1495 tumor cases were captured and diagnosed as one of 18 PTS histotypes. In addition, a PTS biobank network has been created to link clinical data with tumor pathology and molecular analysis.

CONCLUSIONS: This scientific model has not only aggregated a large amount of PTS data, but has also established an international collaborative network of spine oncology centers. Access to large volumes of data will generate further research to guide and enhance PTS clinical management. This model could be applied to other rare neoplastic conditions. Clinical trial registration no.: NCT01643174 (ClinicalTrials.gov).

Original languageEnglish (US)
Pages (from-to)704-710
Number of pages7
JournalJournal of Neurosurgery: Spine
Volume21
Issue number5
DOIs
StatePublished - Nov 1 2014
Externally publishedYes

Fingerprint

Evidence-Based Medicine
Spine
Neoplasms
Morbidity
Molecular Pathology
National Institutes of Health (U.S.)
Medical Records
Demography
Clinical Trials
Recurrence
Mortality

Keywords

  • AOSKFT = AOSpine International Knowledge Forum Tumor
  • FFPE = formalin-fixed paraffinembedded
  • network
  • NIH = National Institutes of Health
  • oncology
  • primary tumor
  • PTS = primary tumor of the spine
  • rare disease
  • scientific model
  • spine
  • surgery
  • WBB = Weinstein-Boriani-Biagini

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Fisher, C. G., Goldschlager, T., Boriani, S., Varga, P. P. A., Rhines, L. D., Fehlings, M. G., ... Gokaslan, Z. L. (2014). An evidence-based medicine model for rare and often neglected neoplastic conditions. Journal of Neurosurgery: Spine, 21(5), 704-710. https://doi.org/10.3171/2014.7.SPINE13954

An evidence-based medicine model for rare and often neglected neoplastic conditions. / Fisher, Charles G.; Goldschlager, Tony; Boriani, Stefano; Varga, Peter P aul; Rhines, Laurence D.; Fehlings, Michael G.; Luzzati, Alessandro; Dekutoski, Mark B.; Reynolds, Jeremy J.; Chou, Dean; Berven, Sigurd H.; Williams, Richard P.; Quraishi, Nasir A.; Bettegowda, Chetan; Gokaslan, Ziya L.

In: Journal of Neurosurgery: Spine, Vol. 21, No. 5, 01.11.2014, p. 704-710.

Research output: Contribution to journalArticle

Fisher, CG, Goldschlager, T, Boriani, S, Varga, PPA, Rhines, LD, Fehlings, MG, Luzzati, A, Dekutoski, MB, Reynolds, JJ, Chou, D, Berven, SH, Williams, RP, Quraishi, NA, Bettegowda, C & Gokaslan, ZL 2014, 'An evidence-based medicine model for rare and often neglected neoplastic conditions', Journal of Neurosurgery: Spine, vol. 21, no. 5, pp. 704-710. https://doi.org/10.3171/2014.7.SPINE13954
Fisher CG, Goldschlager T, Boriani S, Varga PPA, Rhines LD, Fehlings MG et al. An evidence-based medicine model for rare and often neglected neoplastic conditions. Journal of Neurosurgery: Spine. 2014 Nov 1;21(5):704-710. https://doi.org/10.3171/2014.7.SPINE13954
Fisher, Charles G. ; Goldschlager, Tony ; Boriani, Stefano ; Varga, Peter P aul ; Rhines, Laurence D. ; Fehlings, Michael G. ; Luzzati, Alessandro ; Dekutoski, Mark B. ; Reynolds, Jeremy J. ; Chou, Dean ; Berven, Sigurd H. ; Williams, Richard P. ; Quraishi, Nasir A. ; Bettegowda, Chetan ; Gokaslan, Ziya L. / An evidence-based medicine model for rare and often neglected neoplastic conditions. In: Journal of Neurosurgery: Spine. 2014 ; Vol. 21, No. 5. pp. 704-710.
@article{073473f485684155a9b15114cf48bff9,
title = "An evidence-based medicine model for rare and often neglected neoplastic conditions",
abstract = "OBJECT: The National Institutes of Health recommends strategies to obtain evidence for the treatment of rare conditions such as primary tumors of the spine (PTSs). These tumors have a low incidence and are pathologically heterogeneous, and treatment approaches are diverse. Appropriate evidence-based care is imperative. Failure to follow validated oncological principles may lead to unnecessary mortality and profound morbidity. This paper outlines a scientific model that provides significant evidence guiding the treatment of PTSs.METHODS: A four-stage approach was used: 1) planning: data from large-volume centers were reviewed to provide insight; 2) recruitment: centers were enrolled and provided the necessary infrastructure; 3) retrospective stage: existing medical records were reviewed and completed with survival data; and 4) prospective stage: prospective data collection has been implemented. The AOSpine Knowledge Forum Tumor designed six modules: demographic, clinical, diagnostic, therapeutic, local recurrence, survival, and perioperative morbidity data fields and provided funding.RESULTS: It took 18 months to implement Stages 1-3, while Stage 4 is ongoing. A total of 1495 tumor cases were captured and diagnosed as one of 18 PTS histotypes. In addition, a PTS biobank network has been created to link clinical data with tumor pathology and molecular analysis.CONCLUSIONS: This scientific model has not only aggregated a large amount of PTS data, but has also established an international collaborative network of spine oncology centers. Access to large volumes of data will generate further research to guide and enhance PTS clinical management. This model could be applied to other rare neoplastic conditions. Clinical trial registration no.: NCT01643174 (ClinicalTrials.gov).",
keywords = "AOSKFT = AOSpine International Knowledge Forum Tumor, FFPE = formalin-fixed paraffinembedded, network, NIH = National Institutes of Health, oncology, primary tumor, PTS = primary tumor of the spine, rare disease, scientific model, spine, surgery, WBB = Weinstein-Boriani-Biagini",
author = "Fisher, {Charles G.} and Tony Goldschlager and Stefano Boriani and Varga, {Peter P aul} and Rhines, {Laurence D.} and Fehlings, {Michael G.} and Alessandro Luzzati and Dekutoski, {Mark B.} and Reynolds, {Jeremy J.} and Dean Chou and Berven, {Sigurd H.} and Williams, {Richard P.} and Quraishi, {Nasir A.} and Chetan Bettegowda and Gokaslan, {Ziya L.}",
year = "2014",
month = "11",
day = "1",
doi = "10.3171/2014.7.SPINE13954",
language = "English (US)",
volume = "21",
pages = "704--710",
journal = "Journal of Neurosurgery: Spine",
issn = "1547-5654",
publisher = "American Association of Neurological Surgeons",
number = "5",

}

TY - JOUR

T1 - An evidence-based medicine model for rare and often neglected neoplastic conditions

AU - Fisher, Charles G.

AU - Goldschlager, Tony

AU - Boriani, Stefano

AU - Varga, Peter P aul

AU - Rhines, Laurence D.

AU - Fehlings, Michael G.

AU - Luzzati, Alessandro

AU - Dekutoski, Mark B.

AU - Reynolds, Jeremy J.

AU - Chou, Dean

AU - Berven, Sigurd H.

AU - Williams, Richard P.

AU - Quraishi, Nasir A.

AU - Bettegowda, Chetan

AU - Gokaslan, Ziya L.

PY - 2014/11/1

Y1 - 2014/11/1

N2 - OBJECT: The National Institutes of Health recommends strategies to obtain evidence for the treatment of rare conditions such as primary tumors of the spine (PTSs). These tumors have a low incidence and are pathologically heterogeneous, and treatment approaches are diverse. Appropriate evidence-based care is imperative. Failure to follow validated oncological principles may lead to unnecessary mortality and profound morbidity. This paper outlines a scientific model that provides significant evidence guiding the treatment of PTSs.METHODS: A four-stage approach was used: 1) planning: data from large-volume centers were reviewed to provide insight; 2) recruitment: centers were enrolled and provided the necessary infrastructure; 3) retrospective stage: existing medical records were reviewed and completed with survival data; and 4) prospective stage: prospective data collection has been implemented. The AOSpine Knowledge Forum Tumor designed six modules: demographic, clinical, diagnostic, therapeutic, local recurrence, survival, and perioperative morbidity data fields and provided funding.RESULTS: It took 18 months to implement Stages 1-3, while Stage 4 is ongoing. A total of 1495 tumor cases were captured and diagnosed as one of 18 PTS histotypes. In addition, a PTS biobank network has been created to link clinical data with tumor pathology and molecular analysis.CONCLUSIONS: This scientific model has not only aggregated a large amount of PTS data, but has also established an international collaborative network of spine oncology centers. Access to large volumes of data will generate further research to guide and enhance PTS clinical management. This model could be applied to other rare neoplastic conditions. Clinical trial registration no.: NCT01643174 (ClinicalTrials.gov).

AB - OBJECT: The National Institutes of Health recommends strategies to obtain evidence for the treatment of rare conditions such as primary tumors of the spine (PTSs). These tumors have a low incidence and are pathologically heterogeneous, and treatment approaches are diverse. Appropriate evidence-based care is imperative. Failure to follow validated oncological principles may lead to unnecessary mortality and profound morbidity. This paper outlines a scientific model that provides significant evidence guiding the treatment of PTSs.METHODS: A four-stage approach was used: 1) planning: data from large-volume centers were reviewed to provide insight; 2) recruitment: centers were enrolled and provided the necessary infrastructure; 3) retrospective stage: existing medical records were reviewed and completed with survival data; and 4) prospective stage: prospective data collection has been implemented. The AOSpine Knowledge Forum Tumor designed six modules: demographic, clinical, diagnostic, therapeutic, local recurrence, survival, and perioperative morbidity data fields and provided funding.RESULTS: It took 18 months to implement Stages 1-3, while Stage 4 is ongoing. A total of 1495 tumor cases were captured and diagnosed as one of 18 PTS histotypes. In addition, a PTS biobank network has been created to link clinical data with tumor pathology and molecular analysis.CONCLUSIONS: This scientific model has not only aggregated a large amount of PTS data, but has also established an international collaborative network of spine oncology centers. Access to large volumes of data will generate further research to guide and enhance PTS clinical management. This model could be applied to other rare neoplastic conditions. Clinical trial registration no.: NCT01643174 (ClinicalTrials.gov).

KW - AOSKFT = AOSpine International Knowledge Forum Tumor

KW - FFPE = formalin-fixed paraffinembedded

KW - network

KW - NIH = National Institutes of Health

KW - oncology

KW - primary tumor

KW - PTS = primary tumor of the spine

KW - rare disease

KW - scientific model

KW - spine

KW - surgery

KW - WBB = Weinstein-Boriani-Biagini

UR - http://www.scopus.com/inward/record.url?scp=84922391527&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922391527&partnerID=8YFLogxK

U2 - 10.3171/2014.7.SPINE13954

DO - 10.3171/2014.7.SPINE13954

M3 - Article

C2 - 25192373

AN - SCOPUS:84922391527

VL - 21

SP - 704

EP - 710

JO - Journal of Neurosurgery: Spine

JF - Journal of Neurosurgery: Spine

SN - 1547-5654

IS - 5

ER -